Nevertheless, our findings that HIC1 downexpression was associated with the progression and prognosis of ESCC have heralded this molecule to be a promising therapeutic target for intervention of ESCC in the future. The gene discussed is HIC1; the disease is esophageal squamous cell carcinoma.